Eli Lilly and Company has completed acquisition of two biopharmaceutical companies – Versanis Bio and Sigilon Therapeutics - and their lead assets focused on obesity and diabetes.
Lilly announced. -Today at 06:31 pm- MarketScreener
pythons? i did. did you read that story yet in the journal ? i did not. so many pythons have been released, pets, that there are no medium size d animals in the everglades anymore. when he says medium sized he s talking about bobcats, possums. in some areas the population is down 99% because of all these pythons. can you imagine? this is like a movie. they re going to start eating little kids next. let s hope not. so many have been released in the everglades but giant 16-foot-long pythons just slinking around what happened? you re nervous. i m nervous around you with all these pythons. that s why i warned florida voters on their way to the polls got to watch the pythons. we have a busy morning in earnings. you see tyco and mattel just crossing the wire. set to report quarterly results before the bell this morning include exxon mobil, pfizer, u.p.s., archer daniels and eli lilly. oil giant exxon expected to boast earnings of $1.96 a share, higher o